For more than a century, modern medicine has operated on a disease-first model: wait for an organ system to fail, diagnose the specific pathology, and prescribe a targeted therapy.
While this reactive approach has succeeded in managing acute infectious diseases and extending average life expectancy, it struggles with the realities of an aging population. Patients frequently accumulate multiple chronic conditions—such as hypertension, osteoarthritis, prediabetes, and mild cognitive slowing—that are managed in clinical silos with little regard for the individual's overall physiological reserve.
To solve this problem, geriatricians and geroscience researchers have introduced a unifying clinical framework: intrinsic capacity.
Instead of simply counting diseases or cataloging physical deficits, intrinsic capacity measures the sum total of an individual's physical and mental reserves. It provides an objective method to track biological aging, catch subclinical functional decline before disability sets in, and reorient clinical practice around preserving human independence [1].
Here is an evidence-based examination of what intrinsic capacity is, how it is measured, the major health organizations driving its adoption, and how it is reshaping the future of clinical medicine.
1. Defining Intrinsic Capacity
Formally defined by the World Health Organization (WHO) in its 2015 World Report on Ageing and Health, intrinsic capacity is "the composite of all the physical and mental capacities that an individual can draw upon at any point in their life" [1].
To understand intrinsic capacity, it helps to distinguish it from two closely related concepts:
Functional Ability: What an individual can actually accomplish in daily life (such as grocery shopping, preparing meals, or climbing stairs). Functional ability is determined by the interaction between a person's intrinsic capacity and the environment they inhabit. An individual with reduced physical capacity may still maintain high functional ability if they have access to handrails, assistive devices, and social support.
Frailty: A clinical syndrome characterized by increased vulnerability to low-power stressors, resulting from accumulated deficits across multiple physiological systems.
The Interplay Between Frailty and Intrinsic Capacity: While frailty and intrinsic capacity are related, they are not simple mirror images. Frailty assessments focus on the presence of deficits, exhaustion, and acute vulnerability. Intrinsic capacity evaluates positive functional reserves across the lifespan. In midlife and early old age, an individual can experience a measurable decline in intrinsic capacity long before meeting clinical criteria for frailty [2].
Tracking intrinsic capacity offers a continuous, proactive window into health, allowing clinicians to measure reserve and resilience across the entire life course rather than waiting for late-life frailty to manifest.
2. The Organizations Recognizing Intrinsic Capacity
Intrinsic capacity has moved from academic literature into international health policy and regulatory frameworks:
The World Health Organization (WHO): Intrinsic capacity forms the clinical backbone of the UN Decade of Healthy Ageing. In 2017, the WHO released the Integrated Care for Older People (ICOPE) guidelines, creating a standardized public health framework to screen, assess, and manage declines in intrinsic capacity within primary care [3].
International Classification of Diseases (ICD-11): In a major regulatory shift away from characterizing old age as an untreatable disease, the WHO formally updated the ICD-11 coding system to include diagnostic code MG2A: "Ageing associated decline in intrinsic capacity" under general symptoms [4]. This code provides clinicians with a recognized diagnostic category for early functional decline before end-stage disease develops.
Healthspan Clinical Trial Frameworks: In the United States, research consortia and agencies like the Advanced Research Projects Agency for Health (ARPA-H) have explored intrinsic capacity as a foundational framework for evaluating aging interventions. Developing a validated, composite intrinsic capacity score is widely viewed as a promising pathway to establish surrogate endpoints that regulatory bodies like the FDA could accept for trials evaluating candidate geroprotectors.
International Geriatric Societies: Academic organizations, including the International Association of Gerontology and Geriatrics (IAGG) and the Global Leaders on Sarcopenia and Frailty, have embraced intrinsic capacity as a guiding model for person-centered preventive care.
3. The Core Domains: Five Biological Concepts, Six Operational Targets
Under the original WHO conceptual model, intrinsic capacity is grouped into five core domains [1, 2]:
Locomotor Capacity: Neuromuscular coordination, muscular strength, joint range of motion, and balance that enable walking and physical movement.
Vitality: The underlying biological engine, reflecting metabolic reserve, cardiorespiratory fitness, mitochondrial bioenergetics, and nutritional balance [1].
Cognitive Capacity: Information-processing networks, including executive function, episodic memory, processing speed, and attention.
Psychological Capacity: Emotional vitality, mood stability, and coping mechanisms. Psychological well-being directly interacts with physiological aging via autonomic regulation, neuroendocrine pathways, and health behaviors.
Sensory Capacity: The fidelity of vision and hearing.
In clinical practice and within the WHO ICOPE care pathway, sensory capacity is operationally split into vision and hearing, resulting in six distinct assessment targets in real-world clinical implementation [3].
Recognizing sensory decline is critical: uncorrected hearing loss and visual impairment significantly increase cognitive load, accelerate social isolation, and substantially elevate the risk of mechanical falls.
4. How Intrinsic Capacity Is Measured in Clinical Practice
The WHO ICOPE protocol divides intrinsic capacity evaluation into a practical, two-step clinical workflow:
Step 1: Rapid Screening
Designed as an efficient initial check that can be completed in routine primary care visits or community settings:
Locomotion: The 5-times sit-to-stand chair-rise test (flagged if taking 14 seconds or longer).
Vitality: Weight loss assessment (unintentional loss of more than 3 kg or 5% of body weight in 3 months) or reduced appetite.
Cognition: Memory and orientation screening (3-word recall and orientation to date and location).
Psychological: Brief mood assessment (screening for persistent low mood or loss of interest over the past two weeks).
Sensory: Whisper voice test for hearing function; eye-chart reading or self-reported difficulties with near/distance vision.
Step 2: Comprehensive Diagnostic Evaluation
When an individual flags a deficit during the initial screen, clinicians transition to validated, in-depth diagnostic tools:
Locomotion: The Short Physical Performance Battery (SPPB), incorporating a 4-meter gait speed assessment, balance testing, and repeated chair stands.
Vitality: Grip strength dynamometry (identifying dynapenia), the Mini Nutritional Assessment (MNA), body composition scans (measuring appendicular lean mass), and cardiorespiratory fitness evaluations.
Cognition: Formal cognitive batteries such as the Montreal Cognitive Assessment (MoCA).
Psychological: Validated instruments such as the Geriatric Depression Scale (GDS-15) or Patient Health Questionnaire (PHQ-9).
Sensory: Formal pure-tone audiometry and comprehensive ophthalmologic evaluations.
5. How Intrinsic Capacity Is Shifting Clinical Medicine
Transitioning from a disease-focused model to an intrinsic capacity framework represents a major structural shift for clinical practice:
Breaking Down Clinical Silos: Traditional healthcare addresses chronic illnesses independently: a cardiologist manages blood pressure, an endocrinologist manages HbA1c, and an orthopedist manages joint pain. Intrinsic capacity integrates these variables into a unified picture of functional reserve, helping clinicians prioritize therapies that support overall mobility and vitality rather than layering on conflicting medications.
Detecting Subclinical Functional Decline: Biological reserve declines quietly for years before a formal diagnosis occurs. A patient may present with a normal baseline physical exam, but a serial drop in gait speed, grip strength, or cognitive processing speed provides an early warning sign of physiological decline years before an acute hospital admission or fall.
Aligning with Geroscience: Researchers are linking intrinsic capacity to molecular aging markers. Emerging studies show that accelerated epigenetic clocks (such as GrimAge) and chronic inflammatory markers correlate with steeper declines in intrinsic capacity, connecting molecular aging biology directly to functional physical decline [5].
6. Implementation Challenges and Future Directions
While the clinical promise of intrinsic capacity is significant, several practical hurdles remain before it becomes ubiquitous in everyday practice:
Absence of a Universal Composite Score: While individual tools (like the SPPB or MoCA) are well-validated, there is currently no single standardized algorithm that converts all domains into a unified composite metric analogous to a blood pressure reading or cholesterol panel.
Ceiling Effects in Younger and Midlife Populations: The standard ICOPE screening tests were developed to identify impairment in older adults; healthy 45-year-olds easily achieve perfect scores. Expanding intrinsic capacity upstream into midlife prevention requires higher-difficulty physiological benchmarks, such as VO2 max percentiles, reactive agility, and complex executive function testing.
Clinical Time and Reimbursement Constraints: Comprehensive assessments require dedicated clinical time that is difficult to accommodate within high-volume, 15-minute primary care appointments, and traditional insurance models frequently prioritize procedural coding over holistic capacity assessments.
Healthcare is steadily evolving from merely treating established disease toward actively measuring and preserving biological capacity.
Intrinsic capacity provides the clinical framework for that transition. By monitoring the foundational domains of physical and cognitive function—mobility, vitality, cognition, psychological well-being, vision, and hearing—clinicians and individuals can detect early dips in reserve and intervene proactively.
Maintaining lifelong independence is not simply about avoiding individual disease labels; it is about systematically protecting the functional capacity that allows you to remain vibrant, capable, and self-reliant throughout your life course.
References
World Health Organization. World report on ageing and health. World Health Organization; 2015.
Cesari M, Canevelli M, Amuthavalli Thiyagarajan J, et al. Frailty and intrinsic capacity: integrating complementary concepts to promote healthy ageing and transformation of care. Age and Ageing. 2026;55(5):afag138.
World Health Organization. Integrated care for older people: guidelines on community-level interventions to manage declines in intrinsic capacity. World Health Organization; 2017.
World Health Organization. International Classification of Diseases, Eleventh Revision (ICD-11), code MG2A: Ageing associated decline in intrinsic capacity. World Health Organization; 2022.
Rouch L, De Souto Barreto P, Rolland Y, et al. Accelerated Epigenetic and Inflammatory Aging and Intrinsic Capacity. JAMA Network Open. 2026;9(7):e2624102.
Editorial Oversight & Clinical Review
Michael Leone, MD
Physician & Co-Founder, delaeMD
Clinical content at delaeMD is written and reviewed by licensed physicians. Articles are grounded in peer-reviewed evidence and current clinical guidelines, and are intended for education — not as a substitute for individualized medical advice.
